Cargando…
A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity
The potential side effects of cabazitaxel (CBZ) in the field of cancer treatment have become a great limitation to its further clinical application. Liposomal delivery is a well-established approach to increase the therapeutic index of hydrophobic drugs. In this study, a PEG-modified liposome was de...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032206/ https://www.ncbi.nlm.nih.gov/pubmed/32104492 http://dx.doi.org/10.1016/j.ajps.2018.10.004 |